Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics

被引:264
作者
Chen, Ming Hui [3 ,4 ,5 ]
Kerkelae, Risto [1 ,2 ]
Force, Thomas [1 ,2 ,6 ]
机构
[1] Jefferson Med Coll, Ctr Translat Med, Philadelphia, PA 19107 USA
[2] Jefferson Med Coll, Div Cardiol, Philadelphia, PA 19107 USA
[3] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Cardiol, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Womens Hlth, Boston, MA 02115 USA
[6] Jefferson Coll Grad Studies, Program Cell & Dev Biol, Philadelphia, PA USA
关键词
cardiomyopathy; drugs; heart failure; receptors;
D O I
10.1161/CIRCULATIONAHA.108.776831
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:84 / 95
页数:12
相关论文
共 77 条
[1]  
ANDERSON CD, 2007, J SURG RES
[2]   Congestive heart failure is a rare event in patients receiving imatinib therapy [J].
Atallah, Ehab ;
Durand, Jean-Bernard ;
Kantarjian, Hagop ;
Cortes, Jorge .
BLOOD, 2007, 110 (04) :1233-1237
[3]   Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction [J].
Ayach, BB ;
Yoshimitsu, M ;
Dawood, F ;
Sun, M ;
Arab, S ;
Chen, M ;
Higuchi, K ;
Siatskas, C ;
Lee, P ;
Lim, H ;
Zhang, J ;
Cukerman, E ;
Stanford, WL ;
Medin, JA ;
Liu, PP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (07) :2304-2309
[4]   Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors [J].
Bantscheff, Marcus ;
Eberhard, Dirk ;
Abraham, Yann ;
Bastuck, Sonja ;
Boesche, Markus ;
Hobson, Scott ;
Mathieson, Toby ;
Perrin, Jessica ;
Raida, Manfred ;
Rau, Christina ;
Reader, Valerie ;
Sweetman, Gavain ;
Bauer, Andreas ;
Bouwmeester, Tewis ;
Hopf, Carsten ;
Kruse, Ulrich ;
Neubauer, Gitte ;
Ramsden, Nigel ;
Rick, Jens ;
Kuster, Bernhard ;
Drewes, Gerard .
NATURE BIOTECHNOLOGY, 2007, 25 (09) :1035-1044
[5]   Role of the JAK-STAT pathway in myocardial injury [J].
Barry, Sean P. ;
Townsend, Paul A. ;
Latchman, David S. ;
Stephanou, Anastasis .
TRENDS IN MOLECULAR MEDICINE, 2007, 13 (02) :82-89
[6]   Lapatinib in breast cancer [J].
Bilancia, D. ;
Rosati, G. ;
Dinota, A. ;
Germano, D. ;
Romano, R. ;
Manzione, L. .
ANNALS OF ONCOLOGY, 2007, 18 :26-30
[7]   Cardiac toxicity in breast cancer survivors: Review of potential cardiac problems [J].
Bird, Brian R. J. Healey ;
Swain, Sandra M. .
CLINICAL CANCER RESEARCH, 2008, 14 (01) :14-24
[8]   A selective inhibitor-of eIF2α dephosphorylation protects cells from ER stress [J].
Boyce, M ;
Bryant, KF ;
Jousse, C ;
Long, K ;
Harding, HP ;
Scheuner, D ;
Kaufman, RJ ;
Ma, DW ;
Coen, DM ;
Ron, D ;
Yuan, JY .
SCIENCE, 2005, 307 (5711) :935-939
[9]   Angiogenesis in life, disease and medicine [J].
Carmeliet, P .
NATURE, 2005, 438 (7070) :932-936
[10]   Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib [J].
Chu, Tammy F. ;
Rupnick, Maria A. ;
Kerkela, Risto ;
Dallabrida, Susan M. ;
Zurakowski, David ;
Nguyen, Lisa ;
Woulfe, Kathleen ;
Pravda, Elke ;
Cassiola, Flavia ;
Desai, Jayesh ;
George, Suzanne ;
Morgan, Jeffrey A. ;
Harris, David M. ;
Ismail, Nesreen S. ;
Chen, Jey-Hsin ;
Schoen, Frederick J. ;
Van den Abbeele, Annick D. ;
Demetri, George D. ;
Force, Thomas ;
Chen, Ming Hui .
LANCET, 2007, 370 (9604) :2011-2019